## Clinical Context This patient presents with classic pneumococcal pneumonia: fever, rusty sputum, pleurisy, lobar consolidation, and gram-positive diplococci on Gram stain. The clinical presentation is acute and potentially life-threatening. ## Rationale for Correct Answer **Key Point:** In community-acquired pneumonia (CAP) with suspected *Streptococcus pneumoniae*, empiric antibiotics must be started immediately after blood cultures are obtained — not delayed pending culture results. **High-Yield:** The mortality of untreated pneumococcal pneumonia increases significantly with each hour of delay. Empiric therapy is standard of care in acute bacterial pneumonia with clinical and radiological evidence. **Clinical Pearl:** Ceftriaxone is the first-line empiric agent for hospitalized CAP with suspected pneumococcal infection (covers both pneumococci and atypical organisms). The dose of 2 g IV 12-hourly is appropriate for pneumonia. ## Why Ceftriaxone? - Third-generation cephalosporin with excellent lung penetration - Covers *S. pneumoniae* (including penicillin-intermediate strains) and *H. influenzae* - Can add macrolide (azithromycin) or fluoroquinolone if atypical coverage needed - Avoids delays that increase mortality ## Guideline Basis [cite:Harrison 21e Ch 297] and [cite:IDSA CAP Guidelines] emphasize empiric therapy within 1 hour of presentation for hospitalized CAP.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.